Clinical Trial Update: Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of tivantinib in adults with advanced solid tumors and hepatic impairment, reporting PK parameters in these populations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• tivantinib (tivantinib)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Hepatic Impairment, Solid Tumor | Phase 1 | Status: COMPLETED